在多发性髓瘤中,PVT1与多镇压复合体2相互作用,以抑制具有亲亡和瘤抑制功能的基因组区域
Patrick Nylund1, Berta Garrido-Zabala2, Alba Atienza Párraga2
1Science for Life Laboratory, Department of Immunology, Genetic and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala. patrick.nylund@igp.uu.se.
Haematologica
|July 27, 2023
概括
长非编码RNA PVT1 与多发性骨髓瘤中EZH2相互作用,这是一个具有挑战性的血液癌症. 过度表达PVT1与预后不佳相关,这表明它是治疗这种疾病的潜在治疗标.
科学领域:
- 血液学 血液学 血液学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 多发性骨髓瘤是一种异质的血细胞癌,具有具有挑战性的治疗结果.
- 作为PRC2的一部分,表观遗传静音器EZH2的增强活性与预后不佳有关.
- 尽管EZH2的lncRNA结合口袋,但PRC2基因组向的机制仍然不清楚.
研究的目的:
- 在多发性骨髓瘤中识别与EZH2相互作用的长非编码RNA (lncRNAs).
- 调查lncRNA-EZH2相互作用在疾病进展和基因沉默中的作用.
主要方法:
- 在人类多发性髓瘤细胞上进行组合RNA免疫沉测序,RNA测序和ChIP测序.
- 对原始细胞和细胞系进行分析,以识别EZH2相互作用的lncRNAs.
主要成果:
- 确定了血细胞瘤变异转位1 (PVT1) 作为EZH2.2的直接相互作用的lncRNA合作伙伴.
- 在预后不佳的多发性骨髓瘤患者中,PVT1过度表达.
- PVT1的目标是参与瘤抑制和亡的基因,H3K27me3丰富表明了这一点.
结论:
- PVT1与EZH2直接相互作用,并与多发性骨髓瘤中PRC2介导的基因沉默有关.
- 抑制PVT1导致PRC2目标基因的表达增加.
- PVT1代表了多发性骨髓瘤治疗的潜在治疗标.
更多相关视频
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


